Uncategorized
In vivo CAR-T race for autoimmune grows as two RNA startups enter the clinic
In vivo CAR-T race for autoimmune grows as two RNA startups enter the clinic
Two new startups have begun testing their in vivo CAR-T therapies for autoimmune disease in people.
China-based Immorna recently treated a systemic sclerosis patient with an in vivo CAR-T therapy, and the patient’s peripheral B … Read More